Malaria Vaccines Market, By Vaccines Type, Agent , Distribution Channel, and Geography Industry Forecast till 2024 Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased inclination of various healthcare agencies towards addressing this major malady. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working towards developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the largest number of malaria cases and hence, this region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study. Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/37 People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future. The global malaria vaccines market is expected to be valued at US$ 8.5 million in 2018 and is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024). Increasing accessibility and government support to contribute towards the malaria vaccines market growth The WHO has established a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with certain defined goals, one of them aimed at eliminating malaria in at least 10 countries. Similarly, the Indian government has established Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance by various government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Support from such national and global initiatives will drive malaria vaccines market growth during the forecast period. Report includes chapters which deeply display the following deliverable about industry : • Malaria Vaccines Market Research Objective and Assumption • Malaria Vaccines Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Malaria Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Malaria Vaccines Market, By Regions • Malaria Vaccines Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Malaria Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Malaria Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Malaria Vaccines Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Market Dynamics The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market. According to World Health Organization (WHO), in 2015, approximately 292,000 children in Africa died of malaria, at very early age of 5 years. Around 306,000 fatalities associated with malaria were reported worldwide in 2015, out of which around 90% cases were reported in Africa. According to World Health Organization (WHO), first global malaria vaccines will be piloted in the regions of sub-Saharan Africa in 2018, with the funding to around US$ 15 Mn. The program is partly funded by the Bill & Melinda Gates Foundation and African Research Centers. Major regions affected by malaria do not have an appropriate healthcare infrastructure and standard economic conditions, due to which they are unable to pay for the better treatments and drugs. Malaria is common in sub-Saharan and African region, due to poor sanitation and healthcare standards. However, the vaccine is being developed by GSK at their lab in Belgium in collaboration with Path, which is an international non-profit organization. This ensures the cost effectiveness of the vaccine though it has taken around 30 years to develop at a cost of US$ 565 Mn. The company pledges not to make a profit from sales of the vaccine and adheres to the price range of around US$ 5 per shot. Market Taxonomy This report segments the global malaria vaccines market on the basis of vaccines type, by agent, distribution channel, and geography. On the basis of vaccines type, the malaria vaccines market is categorized into Pre-Erythrocytic Vaccine, Erythrocytic Vaccine and Multi-antigen Vaccine. On the basis of agent, the malaria vaccines market is categorized into Plasmodium Falciparum and Plasmodium Vivax. On the basis of distribution channel, the malaria vaccines market is categorized into hospital, clinics, and community centers. For comprehensive understanding of market dynamics, the global malaria vaccines market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market. Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/37 Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.
© Copyright 2024 Paperzz
